Awareness about the Establishment of Clinical Evidence among Community Pharmacists: A Large-scale Survey among Members of the Okayama Pharmaceutical Association

  • Matsumoto Jun
    Department of Personalized Medicine and Preventive Healthcare Sciences, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University Okayama Pharmaceutical Association Academic Panel, Okayama Pharmaceutical Association
  • Itano Madoka
    Okayama Pharmaceutical Association Academic Panel, Okayama Pharmaceutical Association
  • Iwata Naohiro
    Okayama Pharmaceutical Association Academic Panel, Okayama Pharmaceutical Association
  • Oro Masafumi
    Okayama Pharmaceutical Association Academic Panel, Okayama Pharmaceutical Association
  • Kitakaze Chikako
    Okayama Pharmaceutical Association Academic Panel, Okayama Pharmaceutical Association
  • Hirota Ayuko
    Okayama Pharmaceutical Association Academic Panel, Okayama Pharmaceutical Association
  • Makino Katsuhiko
    Okayama Pharmaceutical Association Academic Panel, Okayama Pharmaceutical Association
  • Tateno Tomoyuki
    Okayama Pharmaceutical Association Academic Panel, Okayama Pharmaceutical Association
  • Terai Ryohei
    Okayama Pharmaceutical Association Academic Panel, Okayama Pharmaceutical Association
  • Kenmotsu Hideo
    Okayama Pharmaceutical Association Academic Panel, Okayama Pharmaceutical Association
  • Date Motohide
    Okayama Pharmaceutical Association

Bibliographic Information

Other Title
  • 保険薬局薬剤師におけるエビデンス創出に対する意識:岡山県薬剤師会会員に対する大規模実態調査
  • ホケン ヤッキョク ヤクザイシ ニ オケル エビデンス ソウシュツ ニ タイスル イシキ : オカヤマケン ヤクザイシカイ カイイン ニ タイスル ダイキボ ジッタイ チョウサ

Search this article

Abstract

<p>Community pharmacists in Japan participate in many important clinical cases involving drug therapies. This involvement should be researched and widely publicized to promote evidence-based medicine (EBM). However, the awareness level about the establishment of clinical evidence among community pharmacists remains unknown. Therefore, this large-scale questionnaire survey was conducted among members of the Okayama Pharmaceutical Association to clarify the awareness about the establishment of clinical evidence among community pharmacists to determine the major factors affecting their awareness. Questionnaires requiring open-ended responses were developed in Google Forms. Finally, 366 valid answers were obtained and statistically analyzed based on three aspects: academic conference presentation, research article publication, and research conduct. More than 50% of the participants agreed that they must engage in the establishment of clinical evidence. However, they were unwilling to engage in it by themselves. Additionally, the awareness about the establishment of clinical evidence among participants aged <40 years, who underwent a 6-year course, and with presentation experience was greater than that among participants aged ≥40 years, who underwent a 4-year course and without presentation experience. Thus, age, course duration, and presentation experience are important factors influencing awareness about the establishment of clinical evidence. Further, >70% of the participants did not have enough time to engage in the establishment of clinical evidence, suggesting that reducing workload and ensuring adequate time are necessary for such engagements. Our novel findings may increase the establishment of clinical evidence by community pharmacists, improve community pharmacists’ social standing, and promote EBM in Japan.</p>

Journal

  • YAKUGAKU ZASSHI

    YAKUGAKU ZASSHI 143 (4), 393-404, 2023-04-01

    The Pharmaceutical Society of Japan

References(1)*help

See more

Report a problem

Back to top